Lee, So-Ryoung
Ahn, Hyo-Jeong
Choi, Eue-Keun
Lee, Seung-Woo
Han, Kyung-Do
Oh, Seil
Lip, Gregory Y. H.
Funding for this research was provided by:
Patient-Centered Clinical Research Coordinating Center (PACEN) funded by the Ministry of Health & Welfare, Republic of Korea (HC21C0028)
Article History
Received: 2 November 2022
Accepted: 21 January 2023
First Online: 30 January 2023
Declarations
:
: The authors declare no competing interests.
: Not applicable.
: EKC: Research grants or speaking fees from Abbott, Bayer, BMS/Pfizer, Biosense Webster, Chong Kun Dang, Daewoong Pharmaceutical Co., Daiichi-Sankyo, DeepQure, Dreamtech Co., Ltd., Jeil Pharmaceutical Co. Ltd., Medtronic, Samjinpharm, Seers Technology, and Skylabs. GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, and Daiichi-Sankyo. No personal fees were received. The remaining authors have nothing to disclose.